Mazze, R. S.

Journal Article

Evaluation of insulin glargine and exenatide alone and in combination: a randomized clinical trial with continuous glucose monitoring and ambulatory glucose profile analysis.

Endocrine Practice. 2019

Diurnal glucose exposure profiles of patients treated with lixisenatide before breakfast or the main meal of the day: an analysis using continuous glucose monitoring.

Diabetes/Metabolism Research and Reviews. 2017

A feasibility study of a 3-day basal-bolus insulin delivery device in individuals with type 2 diabetes.

Diabetes care. 2014

Diurnal glucose profiles using continuous glucose monitoring to identify the glucose-lowering characteristics of colesevelam HCl (Welchol).

Endocrine Practice. 2013

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP).

Diabetes Technology & Therapeutics. 2013

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile.

Journal of Diabetes Science and Technology. 2013

International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece.

Diabetes Technology & Therapeutics. 2011

Diurnal glucose patterns of exenatide once weekly: a 1-year study using continuous glucose monitoring with ambulatory glucose profile analysis.

Endocrine Practice. 2009

Evaluating the accuracy, reliability, and clinical applicability of continuous glucose monitoring (CGM): is CGM ready for real time?.

Diabetes Technology & Therapeutics. 2009

Implementation of a systematic approach to diabetes in primary care in Bahia, Brazil improves metabolic outcomes: PRODIBA-Programa de Interiorizacao da Assistencia ao Diabetes na Bahia (Project for Dissemination of Diabetes Care in the State of Bahia).

Diabetic Medicine. 2009

Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis.

Diabetes Technology & Therapeutics. 2008

Partners in advancing care and education solutions study: impact on processes and outcomes of diabetes care.

Population health management. 2008

Physician pay-for-performance. Implementation and research issues.

Journal of General Internal Medicine. 2006

Making sense of glucose monitoring technologies: from SMBG to CGM.

Diabetes Technology & Therapeutics. 2005

Undetected, uncontrolled blood pressure in type 2 diabetes: self-monitored blood pressure profiles.

Blood Pressure. 2004

Characterizing blood pressure control in individuals with Type 2 diabetes: the relationship between clinic and self-monitored blood pressure.

Diabetic Medicine. 2003

Cost-effectiveness of medical nutrition therapy provided by dietitians for persons with non-insulin-dependent diabetes mellitus.

Journal of the American Dietetic Association. 1995

Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent diabetes mellitus: a randomized, controlled clinical trial.

Journal of the American Dietetic Association. 1995

A joint venture with the commonwealth of independent states.

Diabetes care. 1993

Practice guidelines for nutrition care by dietetics practitioners for outpatients with non-insulin-dependent diabetes mellitus: methodologies for field-testing and cost-effectiveness analysis.

Journal of the American Dietetic Association. 1992

Review

An overview of continuous glucose monitoring and the ambulatory glucose profile [review].

Minnesota Medicine. 2011

Intensified diabetes management: lessons from the diabetes control and complications trial [review].

International Journal of Clinical Pharmacology and Therapeutics. 1995

Abstract

Glycemic variability correlated with 1.5-anhydroglucitol (1.5 AHG) but not with markers of oxidation, inflammation, and endothelial function: baseline characteristics of the CAROLINA CGM sub-study [abstract].

Diabetes. 2015

Book

China Initiative for Diabetes Excellence (CIDE): clinical status of 2143 individuals from 27 provinces with type 2 diabetes

2013